Hinge Health, Inc. (HNGE)

Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	-528.26	-11.93	-108.14
Depreciation & Amortization	5.13	5.95	5.63
Stock-Based Compensation	643.01	0.74	1.65
Other Adjustments	53.57	40.74	27.55
Change in Receivables	-26.63	-1.34	-23.13
Changes in Inventories	-4.76	0.61	10.57
Changes in Accounts Payable	29.41	-10.98	11.56
Changes in Unearned Revenue	83.22	77.16	35.97
Changes in Other Operating Activities	-83.25	-51.95	-25.56
Operating Cash Flow	171.44	49	-63.91
Operating Cash Flow Growth	249.87%	-	-
Capital Expenditures	-0.71	-1.04	-1.98
Purchases of Intangible Assets	-5.36	-2.73	-2.64
Purchases of Investments	-472.29	-324.54	-453.34
Proceeds from Sale of Investments	368.59	346.63	459.45
Payments for Business Acquisitions	-4	-	-
Investing Cash Flow	-113.76	18.31	1.5
Issuance of Common Stock	265.2	0.61	0.49
Repurchase of Common Stock	-360.26	-	-
Net Common Stock Issued (Repurchased)	-95.05	0.61	0.49
Other Financing Activities	-55.42	-2.81	-2.85
Financing Cash Flow	-150.47	-2.2	-2.36
Net Cash Flow	-92.79	65.11	-64.76
Free Cash Flow	170.73	47.96	-65.89
Free Cash Flow Growth	255.97%	-	-
FCF Margin	29.04%	12.29%	-22.51%
Free Cash Flow Per Share	3.13	3.54	-5.06
Levered Free Cash Flow	-395.05	7.82	-71.95
Unlevered Free Cash Flow	-518.37	-14.08	-93.84

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q